Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 7306 AL 7320

Hormonal influences on cognition and risk for Alzheimer's disease

Janicki SC, Schupf N.

Curr Neurol Neurosci Rep. 2010 Sep;10(5):359-66. doi: 10.1007/s11910-010-0122-6.

Diabetes type II: a risk factor for depression-Parkinson-Alzheimer?

Riederer P, Bartl J, Laux G, Grünblatt E.

Neurotox Res. 2011 Feb;19(2):253-65. doi: 10.1007/s12640-010-9203-1. Epub 2010 Jun 15.

Clinical practice. Early Alzheimer's disease

Mayeux R.

N Engl J Med. 2010 Jun 10;362(23):2194-201. doi: 10.1056/NEJMcp0910236.

Risk factors for nursing home placement in Alzheimer's disease: a longitudinal study of cognition, ADL, service utilization, and cholinesterase inhibitor treatment

Wattmo C, Wallin AK, Londos E, Minthon L.

Gerontologist. 2011 Feb;51(1):17-27. doi: 10.1093/geront/gnq050. Epub 2010 Jun 20.

Senile myoclonic epilepsy: delineation of a common condition associated with Alzheimer's disease in Down syndrome

De Simone R, Puig XS, Gélisse P, Crespel A, Genton P.

Seizure. 2010 Sep;19(7):383-9. doi: 10.1016/j.seizure.2010.04.008. Epub 2010 Jul 3.

Current therapies and new strategies for the management of Alzheimer's disease

Aderinwale OG, Ernst HW, Mousa SA.

Am J Alzheimers Dis Other Demen. 2010 Aug;25(5):414-24. doi: 10.1177/1533317510372372. Epub 2010 Jul 2.

A phase I trial of deep brain stimulation of memory circuits in Alzheimer's disease

Laxton AW, Tang-Wai DF, McAndrews MP, Zumsteg D, Wennberg R, Keren R, Wherrett J, Naglie G, Hamani C, Smith GS, Lozano AM.

Ann Neurol. 2010 Oct;68(4):521-34. doi: 10.1002/ana.22089.

Differences in regional brain metabolism associated with specific formulations of hormone therapy in postmenopausal women at risk for AD

Silverman DH, Geist CL, Kenna HA, Williams K, Wroolie T, Powers B, Brooks J, Rasgon NL.

Psychoneuroendocrinology. 2011 May;36(4):502-13. doi: 10.1016/j.psyneuen.2010.08.002. Epub 2010 Sep 1.

[Delirium or behavioral and psychological symptoms of dementia in the elderly patient: diagnosis and treatment]

Breil D.

Praxis (Bern 1994). 2010 Sep 8;99(18):1079-88. doi: 10.1024/1661-8157/a000255.

Multiple defects in energy metabolism in Alzheimer's disease

Ferreira IL, Resende R, Ferreiro E, Rego AC, Pereira CF.

Curr Drug Targets. 2010 Oct;11(10):1193-206. doi: 10.2174/1389450111007011193.

Importance of the caspase cleavage site in amyloid-β protein precursor

Bredesen DE, John V, Galvan V.

J Alzheimers Dis. 2010;22(1):57-63. doi: 10.3233/JAD-2010-100537.

Aspirin in Alzheimer's disease: increased risk of intracerebral hemorrhage: cause for concern?

Thoonsen H, Richard E, Bentham P, Gray R, van Geloven N, De Haan RJ, Van Gool WA, Nederkoorn PJ.

Stroke. 2010 Nov;41(11):2690-2. doi: 10.1161/STROKEAHA.109.576975. Epub 2010 Oct 7.

Current treatments for patients with Alzheimer disease

Osborn GG, Saunders AV.

J Am Osteopath Assoc. 2010 Sep;110(9 Suppl 8):S16-26.

Predicting cognitive decline in Alzheimer's disease: an integrated analysis

Lopez OL, Schwam E, Cummings J, Gauthier S, Jones R, Wilkinson D, Waldemar G, Zhang R, Schindler R.

Alzheimers Dement. 2010 Nov;6(6):431-9. doi: 10.1016/j.jalz.2010.04.003.

Alzheimer's disease amyloid hypothesis at crossroads: where do we go from here?

Saxena U.

Expert Opin Ther Targets. 2010 Dec;14(12):1273-7. doi: 10.1517/14728222.2010.528285.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias